Position in VTRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$44,042,703
+$19,487,333 QoQ
Shares Held
2,773,470
+52.6% QoQ
Ownership
0.241%
of shares outstanding
% of Portfolio
1.13%
of 13F equity value
Holder Rank
#48
of 1,020 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DME Capital Management, LP holds $141,822,381 across 2 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (31.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,886,059 | $97,779,678 | |
| 2 | VTRS |
Viatris Inc
This page
|
2,773,470 | $44,042,703 |
All Filings in VTRS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,042,703 | 2,773,470 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $24,555,370 | 1,817,570 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $52,267,229 | 6,000,830 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $72,024,619 | 5,785,110 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $84,409,692 | 7,270,430 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $78,659,979 | 7,399,810 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $53,940,382 | 4,517,620 | Shares | Other | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||